Loading
Latest filing published 12 Dec 2025 for PharmaCyte Biotech, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 12 December 2025, Michael M. Abecassis disclosed a share grant in PharmaCyte Biotech, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration